References
- Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC, Simeoni U. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021 Jan;99:168–176. doi: 10.1016/j.reprotox.2020.10.005
- Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction - part 1. J Matern Fetal Neonatal Med. 2016 Dec;29(24):3977–87. doi: 10.3109/14767058.2016.1152249
- Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost. 2005 Feb;93(2):228–35. doi: 10.1160/TH04-09-0578
- Suparman E, Mose JC, Handono B, Khairini AF. The Difference in Endothelial Progenitor Cells (Epcs Cd34), Clotting Factors, Blood Pressure and Proteinuria among Preeclampsia Model Mice with and without the Administration of Epcs Cd34. Ann Rom Soc Cell Biol. 2021 May 5;25(5):1760–79. Available from:
https://www.annalsofrscb.ro/index.php/journal/article/view/4699 - Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999 Aug 6;85(3):221–8. doi: 10.1161/01.res.85.3.221
- Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 2003 Jun 24;107(24):3059–65. doi: 10.1161/01.CIR.0000077911.81151.30
- Patschan S, Tampe D, Müller C, Seitz C, Herink C, Müller GA, et al. Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation. BMC Musculoskelet Disord. 2016 Aug 12;17:339. doi: 10.1186/s12891-016-1197-2
- Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci. 2010 Jul;17(7):643–52. doi: 10.1177/1933719110366164
- Gussin HA, Bischoff FZ, Hoffman R, Elias S. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Investig. 2002 Nov–Dec;9(6):357–61. doi: 10.1016/s1071-5576(02)00188-0
- Sugawara J, Mitsui-Saito M, Hoshiai T, Hayashi C, Kimura Y, Okamura K. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab. 2005 Mar;90(3):1845–8. doi: 10.1210/jc.2004-0541
- Van Craenenbroeck EM, Van Craenenbroeck AH, van Ierssel S, Bruyndonckx L, Hoymans VY, Vrints CJ, et al. Quantification of circulating CD34+/KDR+/CD45dim endothelial progenitor cells: analytical considerations. Int J Cardiol. 2013 Sep 1;167(5):1688–95. doi: 10.1016/j.ijcard.2012.10.047
- Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1): 3–57. doi: 10.1002/ijgo.13522
- Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 2009 Mar;30 Suppl A:S77–82. doi: 10.1016/j.placenta.2008.12.006
- Colombo E, Marconi C, Taddeo A, Cappelletti M, Villa ML, Marzorati M, et al. Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia. J Physiol. 2012 Feb 1;590(3):519–32. doi: 10.1113/jphysiol.2011.223032
- Mallucci G, Beneventi F, Bergamaschi R, Bizzotto C, Cavagnoli C, De Maggio I, et al. Circulating endothelial progenitor cells during pregnancy in multiple sclerosis. Neurol Sci. 2021 Apr;42(4): 1443–1451. doi: 10.1007/s10072-020-04648-3
- Mousavi SH, Abroun S, Zarrabi M, Ahmadipanah M. The effect of maternal and infant factors on cord blood yield. Pediatr Blood Cancer. 2017 Jul;64(7):e26381. doi: 10.1002/pbc.26381
- Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1572–9. doi: 10.1161/ATVBAHA.107.144972
- Giordano D, Loddo S, Laganà AS, Coppolino G, Zoccali G, Di Benedetto A, et al. Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis. J Matern Fetal Neonatal Med. 2018 Jan;31(2):258–260. doi: 10.1080/14767058.2016.1277703
- Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006; 20:E664–76.
- Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer. 2008 Dec;8(12):942–56. doi: 10.1038/nrc2524
- Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007 Jan;112(1):51–7. doi: 10.1042/CS20060161
- Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 1998 Apr;4(4):377–86. doi: 10.1093/molehr/4.4.377
- Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. 2012 Feb;206(2):163.e1–7. doi: 10.1016/j.ajog.2011.09.019
- Sipos PI, Bourque SL, Hubel CA, Baker PN, Sibley CP, Davidge ST, et al. Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity. J Clin Endocrinol Metab. 2013 Dec;98(12):4953–60. doi: 10.1210/jc.2013-2580
- Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007 Mar 1;109(5):1801–9. doi: 10.1182/blood-2006-08-043471
- King TF, Bergin DA, Kent EM, Manning F, Reeves EP, Dicker P, et al. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab. 2013 Jan;98(1):E33–9. doi: 10.1210/jc.2012-2793
- Monga R, Buck S, Sharma P, Thomas R, Chouthai NS. Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2385–9. doi: 10.3109/14767058.2012.697228
- Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1451–5. doi: 10.1073/pnas.1011293108
- Chang JC, Chen YJ, Chen IC, Lin WS, Chen YM, Lin CH. Perinatal Outcomes After Statin Exposure During Pregnancy. JAMA Netw Open. 2021 Dec 1;4(12):e2141321. doi: 10.1001/jamanetworkopen.2021.41321